(Q38974755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

Waltraud C Schrottmaier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Bettina Wingelhofer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Isabelle Naegelen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Christine Pirker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Thomas Mohr

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Klaus Holzmann

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Walter Berger

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Georg Krupitza

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Michael Grusch

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Christine Gauglhofer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Jakob Paur

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Daniela Huber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Christine Heinzle

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Brigitte Marian

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Rolf Schulte-Hermann

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Bettina Grasl-Kraupp

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

16 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

2331-2338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

A novel monoclonal antibody to fibroblast growth factor 2 effectively inhibits growth of hepatocellular carcinoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Fibroblast growth factor signalling: from development to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Telomerase-immortalized lymphatic and blood vessel endothelial cells are functionally stable and retain their lineage specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

A soluble dominant negative fibroblast growth factor receptor 4 isoform in human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Monitoring viral decontamination procedures with green fluorescent protein-expressing adenovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Integrins and cell-fate determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Integrins as regulators of the mitotic machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Integrins regulate microtubule nucleating activity of centrosome through mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

Hepatocellular Carcinoma (HCC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU151

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGU151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25031272%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference